Ocular Oncology and Pathology
Scope & Guideline
Advancing Knowledge in Ocular Oncology and Pathology
Introduction
Aims and Scopes
- Ocular Tumor Diagnosis and Management:
The journal covers a wide range of ocular tumors, including uveal melanoma, retinoblastoma, and conjunctival melanoma, focusing on innovative diagnostic techniques and treatment modalities. - Pathological Insights into Ocular Conditions:
It provides insights into the histopathological features of various ocular tumors, enhancing the understanding of their biological behavior and potential therapeutic targets. - Multimodal Imaging Techniques:
Research on advanced imaging modalities such as optical coherence tomography and magnetic resonance imaging is emphasized, aiding in the accurate diagnosis and monitoring of ocular tumors. - Therapeutic Innovations:
The journal highlights new treatment approaches, including brachytherapy, stereotactic radiosurgery, and chemotherapy, aiming to improve patient outcomes and minimize side effects. - Epidemiological and Clinical Studies:
It publishes studies on the epidemiology, clinical outcomes, and quality of life related to ocular malignancies, contributing to a comprehensive understanding of these diseases.
Trending and Emerging
- Targeted Therapies and Personalized Medicine:
There is an increasing focus on targeted therapies and personalized medicine, particularly in the context of uveal melanoma and retinoblastoma, as researchers seek to tailor treatments based on individual tumor characteristics. - Integration of Genomic and Molecular Data:
The incorporation of genomic and molecular studies into ocular oncology is on the rise, highlighting the importance of genetic profiling in predicting outcomes and guiding treatment strategies. - Longitudinal Studies on Treatment Outcomes:
Emerging themes include the need for longitudinal studies that assess long-term outcomes of various treatment modalities, reflecting a growing interest in survivorship and quality of life post-treatment. - Multidisciplinary Approaches to Ocular Tumors:
There is a notable trend towards multidisciplinary approaches, combining insights from oncology, pathology, radiology, and surgery to improve comprehensive care for patients with ocular tumors. - Exploration of Immunotherapy:
Research on the role of immunotherapy in the treatment of ocular malignancies is gaining prominence, as there is an increasing interest in harnessing the immune system to combat these cancers.
Declining or Waning
- Traditional Chemotherapy for Ocular Tumors:
There is a noticeable decrease in research focusing solely on traditional chemotherapy approaches for ocular tumors, as newer targeted therapies and immunotherapies gain traction in clinical practice. - Non-Invasive Diagnostic Techniques:
Although still relevant, the emphasis on less invasive diagnostic techniques has diminished, possibly due to the increasing sophistication and accuracy of imaging technologies. - Histopathological Correlation without Clinical Context:
Research that exclusively discusses histopathological findings without correlating them to clinical outcomes is becoming less common, as there is a growing demand for studies that integrate clinical and pathological data.
Similar Journals
Journal of Current Ophthalmology
Illuminating Knowledge: Where Ophthalmology Meets InnovationJournal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.
JAPANESE JOURNAL OF OPHTHALMOLOGY
Shaping Tomorrow's Eye Care TodayJapanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.
Case Reports in Ophthalmological Medicine
Empowering Clinicians with Cutting-Edge InsightsCase Reports in Ophthalmological Medicine, an esteemed journal published by HINDAWI LTD, is a vital resource for researchers and professionals in the field of ophthalmology. With an emphasis on the dissemination of novel case reports and innovative findings, this open-access journal has been providing accessibility to cutting-edge ophthalmological research since 2011, allowing for a broader exchange of knowledge among clinicians and academics. Although specific impact factor and h-index data are not detailed, the journal is committed to fostering a collaborative environment for the global ophthalmology community, promoting evidence-based practices through rigorously peer-reviewed articles. The journal's dedication to open access ensures that valuable insights reach a wider audience, facilitating advancements in patient care and surgical techniques. Case Reports in Ophthalmological Medicine stands as a pivotal platform for sharing diverse clinical experiences, contributing significantly to the enhancement of ophthalmology as a specialty.
JOURNAL FRANCAIS D OPHTALMOLOGIE
Fostering collaboration in the global ophthalmological community.JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.
Expert Review of Ophthalmology
Transforming Knowledge into Visionary CareExpert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
Fostering innovation in eye care research.Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.
OPHTHALMOLOGY
Exploring innovative treatments for complex ocular conditions.OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.
OPHTHALMOLOGICA
Pioneering Research at the Intersection of Vision and ScienceOPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
Advancing knowledge in eye health and innovation.ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.
Head & Neck Pathology
Elevating Research in Head & Neck Oncology and PathologyHead & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.